Back to Top Skip to main content Skip to sub-navigation

Innovative RX pad creates path for prescribing mobile health technology

Military health care provider demonstrates the use of the T2 Mood Tracker app to a patient. Military health care provider demonstrates the use of the T2 Mood Tracker app to a patient.

Recommended Content:

Coronavirus | Public Health

Technology expands the patient provider connection and the ability to continue treatment during difficult times when in person access is limited. Defense Health Agency Connected Health’s Education and Training team works to create tools that will bring mobile health technology to patient care. 

During COVID-19, with states under stay-at-home orders and regular office visits having turned virtual, a provider may be thinking, “How do I begin integrating technology with traditional care?” Many providers are uncertain of how to bridge the technology health gap with their patients. Now, health professionals can use a customized RX pad to formally prescribe mobile health apps to enhance their patient’s treatment plan. Health providers can download the DHA health technology prescription pad from the DHA Connected Health Education and Training website at http://health.mil/mHealthTraining.

DHA Connected Health Education and Training saw a need to help military providers find a trusted way to use mobile health technologies with their patients. The prescription pad enables providers to quickly locate DHA and Department of Veteran Affairs approved mobile health apps. 

“It can be difficult for busy care teams to identify safe and evidence-based health technology to support health issues common in the military community,” said Julie Kinn, DHA Connected Health Education and Training lead. “We wanted to make an easy-to-use resource that can help providers find good tools and make it easy to share these resources with their patients.” 

As healthcare providers begin integrating technology, they may have questions about how to prescribe mobile apps in treatment. 

“My recommendation is to be specific about the timing and how often the patient will use the technology,” Kinn said. “These are guidelines that will benefit both patient and provider as clinical care progresses.”

The prescription pad includes a choice of 24 mobile apps covering topics from mindfulness to post-traumatic stress disorder and mood tracking. Prescribing mobile apps allows a patient to work with a provider on an ongoing basis without being in the same location. This convenience helps to keep the service member on track and involved with a provider even while deployed. The back of the prescription pad provides patients with several additional support and informational resources.

When patients engage with prescribed mobile apps during treatment, they take an active role in their own care. Some studies show patient engagement leads to better health results overall.  

T2 Mood Tracker, for example, allows a patient to track emotions over time and enables the provider to see developing patterns through a report generator. Another highly-rated mobile app is the Virtual Hope Box, which helps patients with positive coping and emotion regulating skills. Patients can personalize the app with their family photos, media, personal messages, inspirational quotes, and music, allowing them to complete meaningful homework assignments between provider visits. Connecting service members to a hopeful experience is the goal.

Technology and healthcare are constantly evolving fields, Kinn said, and DHA Connected Health’s Education and Training program continues to look for ways to support the military health provider with new tools and resources.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.